Markets · Europe · LSE

GSK.L GSK plc

£17.36 -3.07%

Europe · Pharmaceuticals & biotechnology

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

-3.07%

YTD

+7.20%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

£17.73

£17.36

VWAP (n/a)

—

Day high

£17.36

Day low

£17.36

Volume

5.2M

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

Viola Davis partners with GSK to educate adults 50 and older about their shingles risk

Yahoo Finance · Oct 8

GSK (LSE:GSK) Deepens Its Drug Pipeline Through Two Research Partnerships

Yahoo Finance · Oct 8

GSK (LSE:GSK) Stock May Trade Below Fair Value Despite Fresh Cabenuva Trial News

Yahoo Finance · Oct 7

ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia

Yahoo Finance · Oct 6

Cerebras Systems’ Tough 2026 Continues: It’ll Double Soon According to One of The Biggest Global Banks

Yahoo Finance · Oct 5

Abbott Stock And Other Healthcare Dividend Names Built For Supply Chain Shocks

Yahoo Finance · Oct 1

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell GSK.L. Try it in the Lab to size a position and see the risk.